Preparation of anhydrothrombin and characterization of its interaction with natural thrombin substrates

Biochemical Journal

Volumn 354, Issue 2, 2001, Pages 309-313

  Hosokawa, K ^a   Ohnishi, T ^a   Shima, M ^a   Nagata, M ^a   Koide, T ^a  

^a UNIVERSITY OF HYOGO   (Japan)

Author keywords

Factor VIII; Factor XIII; Fibrinogen

Indexed keywords

ANHYDROTHROMBIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; PROTEIN C; SERINE PROTEINASE; SODIUM ION; THROMBIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIALYSIS; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME SUBSTRATE; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; THROMBOSIS;

CHROMATOGRAPHY, AFFINITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FACTOR VIII; FACTOR XIII; FIBRINOGEN; HUMANS; KINETICS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PLASMON RESONANCE; THROMBIN;

EID: 0035281601     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3540309     Document Type: Article

References (35)

1. Activation of the fibrin stabilizing factor of plasma by thrombin
2. The effect of proteolytic enzymes on bovine factor V
3. Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein
4. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity
5. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
6. A dual thrombin receptor system for platelet activation
7. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C
8. Evidence that human α-thrombin is a monovalent cation-activated enzyme
9. +-activated enzyme
10. An allosteric switch controls the procoagulant and anticoagulant activities of thrombin
11. + binding site of thrombin
12. Mechanism of action of thrombin on fibrinogen
13. Refined structure of the hirudin-thrombin complex
14. The relined 1.9 Å crystal structure of human α-thrombin: Interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment
15. The clot thickens: Clues provided by thrombin structure
16. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complex
17. Role of regulatory exosite I in binding of thrombin to human factor V, factor Va, factor Va subunits, and activation fragment
18. The purification by affinity chromatography of a proteinase inhibitor binding species of anhydro-trypsin
19. The preparation of anhydro-trypsin and its reactivity with naturally occurring proteinase inhibitor
20. Mechanism of action of naturally occurring proteinase inhibitors. Studies with anhydrotrypsin and anhydrochymotrypsin purified by affinity chromatography
21. Anhydrotrypsin: New features in ligand interactions revealed by affinity chromatography and thionine replacement
22. Chemical transformation of the active-site serine residue of Streptomyces griseus trypsin to a cysteine residue
23. Human thrombins
24. Common inhibitory effects of human anti-C2 domain inhibitor alloantibodies on factor VIII binding to von Willebrand factor
25. A simple, large scale method for preparation of plasminogen-free fibrinogen
26. Human histidine-rich glycoprotein: Simultaneous purification with antithrombin III and characterization of its gross structure
27. The formation of anhydro-chymotrypsin by removing the elements of water from the serine at active site
28. The resonant mirror: A novel optical biosensor for direct sensing of biomolecular interactions. Part I: Principle of operation and associated instrumentation
29. The resonant mirror: A novel optical biosensor for direct sensing of biomolecular interactions. Part II: Application
30. Measurement of kinetic binding constants of a panel of anti-saporin antibodies using a resonant mirror biosensor
31. Preparation of anhydro-thrombin and its interaction with plasma antithrombin III
32. Stability differences between high coagulant (α) and noncoagulant (γ) human thrombins
33. Preparation and characterization of anhydrothrombin
34. Role of factor VIII C2 domain in factor VIII binding to factor Xa
35. 1689